Share Email Print
cover

Proceedings Paper

First experience of photodithazine clinical application for photodynamic therapy of malignant tumors
Author(s): Eugeny Ph. Stranadko; Gelii V. Ponomarev; V. M. Mechkov; M. V. Ryabov; Andrei V. Ivanov; Andrei V. Reshetnickov; U. M. Koraboyev
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

In 1998 a new second-generation photosensitizer was introduced in Russia - a chlorine derivative named Photodithazine - water-soluble preparation with absorption peak at 668 nm. This novel preparation has passed pre- clinical in vitro and in vivo studies. In 1999 a limited series of clinical testing of photodynamic therapy with photodithazine has been performed in the State Research Center for Laser Medicine of Russian Ministry of Public Health.

Paper Details

Date Published: 29 March 2000
PDF: 7 pages
Proc. SPIE 3909, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IX, (29 March 2000); doi: 10.1117/12.379891
Show Author Affiliations
Eugeny Ph. Stranadko, Ministry of Public Health (Russia)
Gelii V. Ponomarev, Institute of Biomedical Chemistry (Russia)
V. M. Mechkov, Center of New Medical Technologies (Russia)
M. V. Ryabov, Ministry of Public Health (Russia)
Andrei V. Ivanov, N.N. Blokhin Cancer Research Ctr. (Russia)
Andrei V. Reshetnickov, Institute of Biomedical Chemistry (Russia)
U. M. Koraboyev, Ministry of Public Health (Russia)


Published in SPIE Proceedings Vol. 3909:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy IX
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top